Skip to main content
Caplight Logo









CardiaTec

CardiaTec

Private
CambridgeHealthcare & Life Scienceshttps://cardiatec.ai/

Last Round

Seed

Sep 10, 2024

Total Funding Raised

$8.17M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

CardiaTec is a biotechnology company that leverages artificial intelligence and large-scale multi-omics data to discover novel drug targets for cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoverymulti-omicstechbiocardiovascular diseasetarget identificationprecision medicinecomputational biologyai drug discoverydata as a servicebiotechtarget validationin silico drug discoverybiotech platformgenomicsproteomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CardiaTec Comparables

Compare CardiaTec with similar companies based on industry and business-model similarity.

CardiaTec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vasa Therapeutics
83%
Dynomics
82%
G3 Therapeutics
80%

CardiaTec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 10, 2024
Pre SeedJul 6, 2022

Key People

Founding team and executive leadership

Namshik Han

Co-Founder & CTO

Founding Team

Thelma Zablocki

Co-Founder COO

Founding Team

Raphael Peralta

Co-Founder, CEO CardiaTec

Founding Team

CardiaTec Investors

Notable investors and investment history

CardiaTec investors
InvestorRounds
Montage VenturesSeed
o2h venturesPre Seed
APEX VenturesSeed, Pre Seed
Cambridge EnterprisePre Seed
Crista Galli VenturesPre Seed
Continuum Health VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 917% MoM, reaching 1K.

  • Jun 19, 2026

    Monthly visitors grew 443% MoM, reaching 2.3K.

CardiaTec Filings

Explore SEC and related filing metadata, where available.

CardiaTec filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CardiaTec's valuation, stock price, and market status.

Is CardiaTec a public or private company?

CardiaTec is a private company.

What is the current stock price of CardiaTec?

CardiaTec is a private company with no public stock price. No recent secondary market data is available.

How much is CardiaTec worth (valuation)?

Valuation information for CardiaTec is not publicly available.

Can I buy CardiaTec stock?

CardiaTec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CardiaTec's last funding round?

CardiaTec's most recent funding round was Seed on September 10, 2024.

Who are the main investors in CardiaTec?

Key investors in CardiaTec include Montage Ventures, APEX Ventures.

Will CardiaTec IPO soon?

No public IPO plans have been announced for CardiaTec.

How can I track CardiaTec secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CardiaTec's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range13
Year Founded2021
Last FundingSep 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?